Brief: Axsome Therapeutics Q4 Net Income USD -74.912 Million
18/02/2025 12:00
Feb 18 (Reuters) - Axsome Therapeutics Q4 operating income USD -72.617 million. * Q4 operating expenses USD 191.383 million * Q4 basic EPS USD -1.54 * Q4 pretax profit USD -74.827 million
Recent news on Axsome Therapeutics
See all newsUS RESEARCH ROUNDUP-Bright Minds Biosciences, Marvell Technology, Oracle Corporation
Axsome Therapeutics Q3 revenue rises on Auvelity and Sunosi
US RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Axsome Therapeutics Q2 revenue rises on AUVELITY growth